AVATROMBOPAG, A PROMISING NOVEL THROMBOPOIETIN RECEPTOR AGONIST FOR REFRACTORY/RELAPSED/INTOLERANT NON-SEVERE APLASTIC ANEMIA: A PHASE 2 SINGLE-ARM CLINICAL TRIAL

AbstractIntroduction The therapeutic options for thrombocytopenia in non-severe aplastic anaemia (NSAA) are limited.Avatrombopag (AVA) is prescribed for thrombocytopenic diseases but not for NSAA.Methods Herein, we conducted a phase 2, non-randomized, single-arm trial to explore the efficacy and safety of AVA in refractory/relapsed/intolerant NSAA.

Since its origins, cinema has been fascinated with the subject of scientific developments.In particular, astronomy and astrophysics have played an important role in science fiction stories about space travel and exploration.Though the science has not Wheelchair Cushion always been accurately represented, in the last decades there has been more and

Considering contemporary studies on attitudes towards death Metal Skewers and the dead, we will consider, given the documentary, thematic and historical relevance, some epitaphs for females present in the region of Mediolanum, the modern city of Milan.We know that, although we do not have remains of necropolises, as in Isola Sacra, the mortuary evi

Associated radioactive mines are widely distributed in China, with many industries, complex processes and technologies, close relationship with the public, and great impact on the radiation Joint Support environment.They are relatively weak links in nuclear and radiation safety supervision.In the process of implementing the upper level document, so